-
Anti Reverse Cap Analog (ARCA): Revolutionizing mRNA Capp...
2025-09-24
Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, sets a new standard as a synthetic mRNA capping reagent for enhanced translation. This in-depth analysis unveils ARCA’s molecular specificity, its synergy with metabolic regulation, and its transformative potential in precision gene expression and mRNA therapeutics research.
-
3X (DYKDDDDK) Peptide: Precision Tools for Ubiquitin-Medi...
2025-09-23
Explore how the 3X (DYKDDDDK) Peptide advances the study of ubiquitin-dependent protein regulation, offering enhanced sensitivity for immunodetection and affinity purification of FLAG-tagged proteins. This article highlights its unique role in dissecting protein degradation pathways and metal-dependent ELISA assays.
-
5-Methyl-CTP: Enhancing mRNA Vaccine Platforms via Modifi...
2025-09-22
Explore how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, advances mRNA synthesis with modified nucleotides to improve mRNA stability and translation efficiency for research and mRNA drug development.
-
Elafibranor
2025-09-19
-
ARCA EGFP mRNA: Advancing Quantitative Fluorescence-Based...
2025-09-19
Explore the applications and mechanistic advantages of ARCA EGFP mRNA as a direct-detection reporter mRNA for quantitative assessment of transfection efficiency and gene expression in mammalian cells, with a focus on mRNA stability enhancement and co-transcriptional capping with ARCA.
-
Biotin-PEG3-aldehyde
2025-09-19
-
Tivozanib (AV-951)
2025-09-18
-
Enhancing Genome Editing Precision with EZ Cap™ Cas9 mRNA...
2025-09-18
Explore how EZ Cap™ Cas9 mRNA (m1Ψ) advances CRISPR-Cas9 genome editing by integrating mRNA stability, immune evasion, and translational efficiency strategies. This article details the molecular innovations and recent research insights informing next-generation genome editing in mammalian cells.
-
ABBV-744
2025-09-18
-
Glucosyl-vitexin
2025-09-17
-
Fmoc-D-Lys(Boc)-OH
2025-09-17
-
Nutlin-3a chiral
2025-09-16
-
Emedastine
2025-09-16
-
MK-5172 hydrate
2025-09-15
-
Inotuzumab
2025-09-15